v3.21.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenues $ 50,895,151 $ 16,575,395
Revenues from related party 29,029,249
Total revenues 50,895,151 45,604,644
Cost of revenues 19,570,257 26,902,916
Gross profit 31,324,894 18,701,728
Operating expenses:    
Personnel 5,501,756 3,841,725
Marketing and promotion 410,626 369,577
General and administrative 9,899,367 8,818,929
Bad debts 982,488 44,539,820
Goodwill write-downs 2,662,669
Total operating expenses 16,794,237 60,232,720
Operating income (loss) 14,530,657 (41,530,992)
Non-operating income (expenses):    
Interest expense (9,810,475) (12,718,952)
Interest income 156,345 467,798
Loss on debt settlements (44,678) (5,180)
Earnings (losses) of equity investments 98,813 (30,334,503)
Change in fair value of investments (349,638) (640,856)
Other (84,708) 2,948,917
Total non-operating expenses, net (10,034,341) (40,282,776)
Income (loss) before income taxes 4,496,316 (81,813,768)
Provision for income taxes 2,067,049 67,157
Net income (loss) 2,429,267 (81,880,925)
Net income (loss) attributable to noncontrolling interests 285,278 (696,206)
Net income (loss) attributable to MariMed Inc. $ 2,143,989 $ (81,184,719)
Net income (loss) per share    
Basic $ 0.01 $ (0.39)
Diluted $ 0.01 $ (0.39)
Weighted average common shares outstanding    
Basic 266,980,197 208,720,496
Diluted 324,160,525 208,720,496

Source